Delivery Order SPE2DB20D1110-SPE2DB25FK31A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,298.15 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on July 29, 2025, with completion expected by July 30, 2025. This firm fixed price delivery order represents a continuation of the company's extensive pharmaceutical and medical supply support to federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,749.81 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 31, 2025. This non-set-aside contract employs firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,695.80 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and represents a child delivery order under a larger contract vehicle. The sensors will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $11,417.34 to AmerisourceBergen Drug Corp for the supply of FreeStyle Libre 3 sensors under contract number 4568914350. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 29, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The FreeStyle Libre 3 sensor is a continuous...
- The Defense Logistics Agency awarded a $18,977.55 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Sensors on July 24, 2025, with completion targeted for July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $2,300.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Sensors on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical vendor for federal...
- The Defense Logistics Agency awarded a $8,587.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-set-aside contract represents a single delivery order for continuous glucose monitoring sensors to support federal medical supply needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $6,972.90 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,698.64 by the Defense Logistics Agency (DLA) for Freestyle Libre 3 Sensors, with an ultimate completion date of July 30, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical and medical supply distribution activities supporting federal healthcare needs, particularly...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,216.95 for Freestyle Libre 3 Plus Sensors on July 21, 2025, with a completion date of July 22, 2025. This firm fixed price, non-set-aside contract represents a continuation order under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the company's corporate office...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK31ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,768.98 to AmerisourceBergen Drug Corp for the supply of FreeStyle Libre 3 Sensors, with an ultimate completion date of August 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. FreeStyle Libre 3 Sensors are continuous glucose monitoring devices used for diabetes management and align with AmerisourceBergen's established portfolio of diabetes-related pharmaceutical and medical device deliveries to federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 8/1/25 |